Contents
pdf Download PDF pdf Download XML
674 Views
644 Downloads
Share this article
Research Article | Volume 7 Issue 2 (None, 2013) | Pages 46 - 48
A Filipino male with encephalocraniocutaneous lipomatosis (Haberland’s syndrome)
 ,
Under a Creative Commons license
Open Access
PMID : PMC3710677
Received
Feb. 27, 2012
Published
June 30, 2013
Abstract

Background:Encephalocraniocutaneous lipomatosis (ECCL), also known as Haberland’s Syndrome, is a sporadically occurring neurocutaneous syndrome with no gender or race predilection. ECCL patients present with a broad spectrum of clinical manifestations, often in a unilateral distribution. The hallmark of ECCL is the nevus psiloliparus, a soft, bulging, lipomatous scalp lesion, with associated alopecia.Main observations: We describe a case of a 2-month-old Filipino male with a soft, ill-defined mass with associated alopecia on the fronto-parietal scalp. Biopsy revealed findings consistent with a nevus psiloliparus. The patient also presented with a lipomatous nodule on the right temple, as well as choristomas and a coloboma on the right eye. He had no history of seizures and development was at par with age.Conclusion:Recognition of ECCL is important in order to work-up the patient for concomitant problems, such as central nervous system and cardiac anomalies, and employ a multidisciplinary approach in the management of these patients.

Keywords
Recommended Articles
Research Article
Coexistence of Psoriasis and Alopecia Universalis: A Rare Clinical Association
...
Published: 26/09/2026
Research Article
WNT-activated deep penetrating melanocytoma arising within a congenital melanocytic nevus in a pediatric patient: a case report
...
Published: 26/09/2026
Case Report
Pellagra-like presentation of borderline tuberculoid Hansen disease with a Type 1 lepra reaction: a diagnostic mimic
Published: 18/09/2026
Research Article
Analgesic Efficacy of Pericapsular Nerve Group Block versus Femoral Nerve Block before Spinal Anaesthesia for Hip Surgery: A Randomized Trial
Published: 08/08/2024
© Copyright Spejalisci Dermatolodzy